All News Releases
Stanford researchers find that blood test accurately predicts lymphedema
NCI Cancer Center News
(Posted: 12/19/2012) - Scientists have identified a set of proteins circulating in blood whose levels accurately flag the presence of lymphedema, an often-painful condition that can afflict cancer patients.

Mayo Clinic researchers identify enzyme linked to prostate cancer
NCI Cancer Center News
(Posted: 12/19/2012) - Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer.

UCSD researchers find that cancer cells co-opt immune response to escape destruction
NCI Cancer Center News
(Posted: 12/19/2012) - Researchers at the University of California, San Diego School of Medicine report that tumor cells use stress signals to subvert responding immune cells, exploiting them to actually boost conditions beneficial to cancer growth.

MIT researchers find new technology may enable earlier cancer diagnosis
NCI Cancer Center News
(Posted: 12/19/2012) - A new technology developed at MIT may help to make biomarker detection much easier. The researchers, led by Sangeeta Bhatia, have developed nanoparticles that can home to a tumor and interact with cancer proteins to produce thousands of biomarkers.

University of Wisconsin researchers find a new form of cell division
NCI Cancer Center News
(Posted: 12/18/2012) - Researchers at the University of Wisconsin Carbone Cancer Center have discovered a new form of cell division in human cells. They believe it serves as a natural back-up mechanism during faulty cell division, preventing some cells from going down a path that can lead to cancer.

Harnessing the ID in glioma
NCI Cancer Center News
(Posted: 12/18/2012) - In the Journal of Clinical Investigation, researchers led by Antonio Iavarone at Columbia University report on the role of ID proteins in glioma.

UCLA researchers and others find that new technology allows scientists to capture and preserve cancer cells circulating in the bloodstream
NCI Cancer Center News
(Posted: 12/18/2012) - Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.

UCSF study examines risk reduction and screening for ovarian cancer among women following BRCA testing
NCI Cancer Center News
(Posted: 12/18/2012) - Following BRCA testing, many women who are non-BRCA carriers undergo risk-reducing procedures and additional ovarian cancer screenings, despite limited data to determine the effectiveness of these interventions among the general population.

Georgetown study uncovers mechanism used by BRCA1 to suppress tumors
NCI Cancer Center News
(Posted: 12/18/2012) - A new study by Georgetown University Medical Center researchers reveals how a well-known tumor suppressor gene may be functioning to stop cancer cell growth.

Mayo Clinic-led study unravels biological pathway that controls the leakiness of blood vessels
NCI Cancer Center News
(Posted: 12/18/2012) - A research team led by scientists at Mayo Clinic in Florida have decoded the entire pathway that regulates leakiness of blood vessels, a condition that promotes a wide number of disorders, such as heart disease, cancer growth and spread, inflammation and respiratory distress.

NCI Cancer Center News
(Posted: 12/19/2012) - Scientists have identified a set of proteins circulating in blood whose levels accurately flag the presence of lymphedema, an often-painful condition that can afflict cancer patients.
Mayo Clinic researchers identify enzyme linked to prostate cancer
NCI Cancer Center News
(Posted: 12/19/2012) - Researchers at Mayo Clinic's campus in Florida have identified an enzyme specifically linked to aggressive prostate cancer, and have also developed a compound that inhibits the ability of this molecule to promote the metastatic spread of the cancer.
UCSD researchers find that cancer cells co-opt immune response to escape destruction
NCI Cancer Center News
(Posted: 12/19/2012) - Researchers at the University of California, San Diego School of Medicine report that tumor cells use stress signals to subvert responding immune cells, exploiting them to actually boost conditions beneficial to cancer growth.
MIT researchers find new technology may enable earlier cancer diagnosis
NCI Cancer Center News
(Posted: 12/19/2012) - A new technology developed at MIT may help to make biomarker detection much easier. The researchers, led by Sangeeta Bhatia, have developed nanoparticles that can home to a tumor and interact with cancer proteins to produce thousands of biomarkers.
University of Wisconsin researchers find a new form of cell division
NCI Cancer Center News
(Posted: 12/18/2012) - Researchers at the University of Wisconsin Carbone Cancer Center have discovered a new form of cell division in human cells. They believe it serves as a natural back-up mechanism during faulty cell division, preventing some cells from going down a path that can lead to cancer.
Harnessing the ID in glioma
NCI Cancer Center News
(Posted: 12/18/2012) - In the Journal of Clinical Investigation, researchers led by Antonio Iavarone at Columbia University report on the role of ID proteins in glioma.
UCLA researchers and others find that new technology allows scientists to capture and preserve cancer cells circulating in the bloodstream
NCI Cancer Center News
(Posted: 12/18/2012) - Scientists from the RIKEN Advanced Science Institute in Japan and University of California Los Angeles report a new nanoscale Velcro-like device that captures and releases tumor cells that have broken away from primary tumors and are circulating in the bloodstream.
UCSF study examines risk reduction and screening for ovarian cancer among women following BRCA testing
NCI Cancer Center News
(Posted: 12/18/2012) - Following BRCA testing, many women who are non-BRCA carriers undergo risk-reducing procedures and additional ovarian cancer screenings, despite limited data to determine the effectiveness of these interventions among the general population.
Georgetown study uncovers mechanism used by BRCA1 to suppress tumors
NCI Cancer Center News
(Posted: 12/18/2012) - A new study by Georgetown University Medical Center researchers reveals how a well-known tumor suppressor gene may be functioning to stop cancer cell growth.
Mayo Clinic-led study unravels biological pathway that controls the leakiness of blood vessels
NCI Cancer Center News
(Posted: 12/18/2012) - A research team led by scientists at Mayo Clinic in Florida have decoded the entire pathway that regulates leakiness of blood vessels, a condition that promotes a wide number of disorders, such as heart disease, cancer growth and spread, inflammation and respiratory distress.

